India’s negotiation with the European Free Trade Association (EFTA) has raised concerns among pro public health groups. They fear that the discussions may involve TRIPS-plus intellectual property (IP) features. The India-EFTA trade deal negotiations have attracted attention due to the potential impact on public health and access to medicines. This development highlights the ongoing debate surrounding the importance of striking a balance between protecting IP rights and ensuring affordable and accessible healthcare for all.